SCHEMBL31489235

SCHEMBL31489235

CC(F)(F)[C@@H](c1ccc(F)cc1)n1cc(-c2nc(Cl)ncc2F)cn1

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CCNE2 O96020 2/20 0.33
CCNE1 P24864 2/20 0.33
CDK2 P24941 2/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.31
JAK2 O60674 3/20 0.31
FLT3 P36888 3/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
KDM4E B2RXH2 1/20 0.31
GPR55 Q9Y2T6 1/20 0.31
CCNB2 O95067 2/20 0.30
CDK1 P06493 2/20 0.30
CCNB1 P14635 2/20 0.30
CDK5 Q00535 2/20 0.30
CDK5R1 Q15078 2/20 0.30
CCNB3 Q8WWL7 2/20 0.30
CCNT1 O60563 1/20 0.30
CDK9 P50750 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31489663 0.90 JAK2 (0.34) PTGDR2JAK2FLT3SMN1; SMN2KDM4E
SCHEMBL31489637 0.83 MKNK1 (0.39) JAK2SMN1; SMN2KDM4EGPR55
SCHEMBL31489493 0.80 CREBBP (0.32) PTGDR2
SCHEMBL31489816 0.76 CYP11B2 (0.40) JAK2SMN1; SMN2KDM4E
SCHEMBL31489553 0.76 CYP11B2 (0.40) JAK2SMN1; SMN2KDM4E
SCHEMBL31489309 0.76 PDK2 (0.34) SMN1; SMN2KDM4E
SCHEMBL31489570 0.75 MKNK1 (0.40) JAK2SMN1; SMN2KDM4EGPR55
SCHEMBL31334291 0.72 GRM4 (0.45) SMN1; SMN2KDM4E
SCHEMBL30595813 0.72 JAK2 (0.33) CCNE2CCNE1CDK2JAK2FLT3
SCHEMBL31489550 0.72 CYP26A1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072395-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-03 WO disclosed